Table 2 Prevalence of m.1555 A>G mutation in individuals with hearing loss and the general population.

Japan

3.45% (11/319) of outpatients with HL

⁶

Indonesia

5.3% (4/75) of deafness patients

¹⁵

Greece

0.42% (2/478) of patients with NSHL

¹⁶

China

3.96% (65/1,642) of individuals with NSHL

¹⁷

3.96% (69/1,742) of individuals with NSHL

¹⁸

1.6% (7/434) of individuals with NSHL

¹⁹

7.5% (33/440) of individuals with HL

²⁰

5.93% (39/658) of individuals with NSHL

²¹

6.03% (28/464) of individuals with NSHL

²²

3.87% (6/155) of individuals with HL

²³

10.17% (6/59) of individuals with NSHL

²⁴

1.92% (3/156) of individuals with NSHL

²⁵

Spain

17% (9/54) of deafness patients

²⁶

United States

0.2% (3/1,473) of general population

²⁷

China

0.7% (6/865) of newborns

²⁸

0.16% (16/10,043) of neonates

²⁹

0.08% (1/1,181) of newborns

³⁰

0.17% (101/58,397) of neonates

³¹

Europe

0.19% (18/9,371) of children in ALSPAC birth cohort

³²

Australia

0.21% (6/2,856) of general population > age 49

³³

Germany

0.2% (12/7,056) of newborns

³⁴

South Africa

0.5% (1/204) of general population

³⁵

Taiwan

0.1% (1/1,017) of newborns

³⁶

Japan

0.06% (1/1,683) of general population

This study